Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motaz Qadan

Showing results (201-210 of 223) with videos related to

Pageof 23
Sort By:
Annals of Surgery|October 13, 2023
Feasibility, Safety, and Efficacy of Aggressive Multimodal Management of Elderly Patients With Pancreatic Ductal AdenocarcinomaGuoliang Qiao, Zhi Ven Fong, Louisa Bolm, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2019
Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall SurvivalNina N Sanford, Jennifer Pursley, Bridget Noe, et al.
Cancer Research Communications|January 30, 2026
Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint InhibitorsNussara Pakvisal, Leontios Pappas, Bennett A Caughey, et al.
Journal of the National Cancer Institute|June 5, 2020
Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant TherapyTheodoros Michelakos, Lei Cai, Vincenzo Villani, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 23, 2021
Pancreatic acinar cell carcinoma: A multi-center series on clinical characteristics and treatment outcomesVishwajith Sridharan, Mari Mino-Kenudson, James M Cleary, et al.
Annals of Surgery|December 6, 2019
Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional StudyAlessandra Pulvirenti, Georgios A Margonis, Vicente Morales-Oyarvide, et al.
Surgery|November 14, 2021
Pathological treatment response has different prognostic implications for pancreatic cancer patients treated with neoadjuvant chemotherapy or chemoradiotherapyShimpei Maeda, Michael A Mederos, Akhil Chawla, et al.
Journal of Geriatric Oncology|January 25, 2022
Effects of a perioperative geriatric intervention for older adults with Cancer: A randomized clinical trialRyan D Nipp, Carolyn L Qian, Helen P Knight, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2020
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRIDerek J Erstad, Mozhdeh Sojoodi, Martin S Taylor, et al.
Theranostics|September 30, 2024
Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studiesShadi A Esfahani, Hua Ma, Shriya Krishna, et al.
Pageof 23

Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
Annals of Surgery|October 13, 2023
Feasibility, Safety, and Efficacy of Aggressive Multimodal Management of Elderly Patients With Pancreatic Ductal AdenocarcinomaGuoliang Qiao, Zhi Ven Fong, Louisa Bolm, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2019
Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall SurvivalNina N Sanford, Jennifer Pursley, Bridget Noe, et al.
Cancer Research Communications|January 30, 2026
Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint InhibitorsNussara Pakvisal, Leontios Pappas, Bennett A Caughey, et al.
Journal of the National Cancer Institute|June 5, 2020
Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant TherapyTheodoros Michelakos, Lei Cai, Vincenzo Villani, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 23, 2021
Pancreatic acinar cell carcinoma: A multi-center series on clinical characteristics and treatment outcomesVishwajith Sridharan, Mari Mino-Kenudson, James M Cleary, et al.
Annals of Surgery|December 6, 2019
Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional StudyAlessandra Pulvirenti, Georgios A Margonis, Vicente Morales-Oyarvide, et al.
Surgery|November 14, 2021
Pathological treatment response has different prognostic implications for pancreatic cancer patients treated with neoadjuvant chemotherapy or chemoradiotherapyShimpei Maeda, Michael A Mederos, Akhil Chawla, et al.
Journal of Geriatric Oncology|January 25, 2022
Effects of a perioperative geriatric intervention for older adults with Cancer: A randomized clinical trialRyan D Nipp, Carolyn L Qian, Helen P Knight, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2020
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRIDerek J Erstad, Mozhdeh Sojoodi, Martin S Taylor, et al.
Theranostics|September 30, 2024
Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studiesShadi A Esfahani, Hua Ma, Shriya Krishna, et al.
Pageof 23